Paradoxically, the most notable pharmacological role of PPARγ ligands is their ability to improve insulin sensitivity, hyperglycemia and dyslipidemia in type 2 diabetes mellitus7, 8. This evidence concerns the gene PPARG and metabolic syndrome.